Recently active
Unread page 2
On the live site this tab tracks what you have not read. In this static rendering it shows every topic with activity in the last 45 days, which is the closest honest equivalent — we would rather explain the difference than pretend a static page knows your reading history.
414 topics · page 2 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
|
+87 | 101 | 27k | 4h |
|
Reused chromatograms across lots: how to spot it
On the subject in the title: Reused chromatograms across lots: how to spot it Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of…
|
+53 | 60 | 9.5k | 4h |
|
When a network meta-analysis is defensible and when it is not
When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with LEADER (…
|
2 | 27k | 4h | |
|
How the vendor documentation pages are maintained, and by whom
How the vendor documentation pages are maintained, and by whom I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to talk about documentation quality as a…
|
2 | 6k | 4h | |
|
Mobile reading experience on long topics
Mobile reading experience on long topics Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The topic in…
|
2 | 14k | 4h | |
|
Named, unnamed and unspecified impurities as regulatory categories — the long version
Named, unnamed and unspecified impurities as regulatory categories — the long version — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical…
|
+112 | 120 | 7.6k | 5h |
|
Repeatability versus intermediate precision — what changed since
Posting this under the heading it deserves: Repeatability versus intermediate precision — what changed since Everything below is what sits behind that. Working through the identity arithmetic and I would like…
|
4 | 21k | 5h | |
|
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
2 | 7.3k | 5h | |
|
Sleep quality changes during weight loss
On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in this class mostly…
|
+27 | 31 | 555 | 5h |
|
What other technical communities get right that we do not
What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. Lower-stakes topic, but the sourcing rule still applies if…
|
+2 | 6 | 23k | 5h |
|
About the Mass spectrometry category
LC-MS and high-resolution MS, charge states, mass accuracy in ppm, and what identity confirmation does and does not establish. This post is a community wiki: any member at trust level 3 or above can edit it,…
|
+5 | 9 | 19k | 6h |
|
What TRIUMPH is designed to answer, and why we should not pre-empt it
What TRIUMPH is designed to answer, and why we should not pre-empt it I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in…
|
+4 | 8 | 142 | 6h |
|
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021)…
|
2 | 17k | 6h | |
|
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+4 | 8 | 38k | 6h |
|
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree
Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will…
|
+69 | 76 | 920 | 6h |
|
What I would want from a home test that does not exist yet
The question in the title: What I would want from a home test that does not exist yet I will give what I have already checked below so nobody repeats it. A documentation question rather than an analytical…
|
+46 | 50 | 8k | 6h |
|
A supplier who responds to a discrepancy with silence — what changed since
A supplier who responds to a discrepancy with silence — what changed since — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+83 | 88 | 21k | 6h |
|
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this…
|
2 | 18k | 6h | |
|
[2026 update] Correlation in a self-tracked dataset: what it can support
Posting this under the heading it deserves: Correlation in a self-tracked dataset: what it can support Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA , 2024) cited in support of a…
|
2 | 31k | 6h | |
|
SURPASS-2 and the comparator dose question that will not go away — what changed since
Posting this under the heading it deserves: SURPASS-2 and the comparator dose question that will not go away — what changed since Everything below is what sits behind that. Session topic: STEP 8 ( JAMA ,…
|
+2 | 6 | 5.5k | 7h |
|
Compounds this community declines to help with, and why — does this still hold?
Compounds this community declines to help with, and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SCALE ( N Engl J Med ,…
|
+3 | 7 | 26k | 7h |
|
Reconstituting a multi-strength kit without mixing yourself up — what changed since
On the subject in the title: Reconstituting a multi-strength kit without mixing yourself up — what changed since Working notes rather than a conclusion. Practical question with the units stated, because I…
|
+42 | 46 | 1k | 7h |
|
A site rotation scheme that is easy enough to actually follow — a second dataset
A site rotation scheme that is easy enough to actually follow — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated,…
|
+6 | 10 | 1.2k | 7h |
|
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold?
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity…
|
2 | 4.6k | 7h | |
|
Reading a home test result without over-claiming
Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+124 | 137 | 19k | 7h |
|
Joined after a search result and stayed
Posting this under the heading it deserves: Joined after a search result and stayed Everything below is what sits behind that. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim.…
|
+5 | 9 | 26k | 7h |
|
Documenting a supplier's response to a discrepancy
On the subject in the title: Documenting a supplier's response to a discrepancy Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked…
|
+44 | 49 | 589 | 8h |
|
Coming back to: Why our vendor pages link the storefront and mark it sponsored
Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
2 | 22k | 8h | |
|
Revisiting: Body image changing more slowly than the body
Posting this under the heading it deserves: Revisiting: Body image changing more slowly than the body Everything below is what sits behind that. General question, not a request for advice about my own care —…
|
+5 | 9 | 28k | 8h |
|
The SOUL trial and oral semaglutide cardiovascular outcomes
Posting this under the heading it deserves: The SOUL trial and oral semaglutide cardiovascular outcomes Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it…
|
2 | 7.1k | 9h |